50 in 50

Reflecting on 50 Years of Biotech Innovation

50 in 50

In 2026, biotechnology marks 50 years of U.S.-born innovation - five decades that have transformed how the world prevents disease, treats illness, and advances health.

From breakthrough medicines and lifesaving vaccines to a biomanufacturing ecosystem that supports communities across the world, biotechnology has shaped modern medicine, strengthened our economy, and reinforced America’s global leadership.

To mark this milestone, BIO is launching 50 in 50 - a year-long series capturing reflections on the last 50 years of biotech innovation, told in 50 seconds or less.


Include Your Voice


Interested in participating in BIO's 50 in 50 year-long activation? We want to hear from you! Complete this brief questionnaire to help us better understand your interest and preferred topic or perspective.